Skip to main content
Sign In

An official website of the United States government

U.S. Department of Health & Human Services

Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Appendix A: Implementation Timelines


Goal 1: Identify needs to protect Americans against current and emerging threats

Objective
 Description
 Timeline
Objective 1.1
 Conduct regular threat horizon scans to better prepare for CBRN and EID threats, as well as novel and emerging and public health threats, and integrate the full range of solutions (including Non-Pharmaceutical Interventions) into MCM preparedness and response plans Within 273 days of SIP approval
Objective 1.2 Integrate threat characterization and risk analysis information into MCM portfolio considerations including an assessment of tradeoffs and future development pathways Within 273 days of SIP approval
Objective 1.3 Develop portfolio optimization strategies that include an evaluation of development challenges and opportunities as well as end user needs Within 365 days of SIP approval
Objective 1.4 Implement all of the above into a capabilities-based requirements process and utilization framework Within 365 days of SIP approval


Goal 2: Develop strategies to address identified gaps and assess opportunities for continuous improvement


Objective
 Description
 Timeline
Objective 2.1
 Engage with established advisory committees, senior leader councils, SLTT authorities, and non-governmental organizations (domestic and international) to identify the challenges within the MCM enterprise Within 180 days of SIP approval
Objective 2.2 Establish a plan for rapid identification of MCM gaps that prioritizes and coordinates expedited advanced R&D to close those gaps during emerging pandemics, and rapidly assess safety and efficacy of novel MCMs Within 365 days of SIP approval
Objective 2.3 Outline short-, medium-, and long-term R&D priorities for the end-to-end MCM development cycle and adjust based on strategic environment and threat assessment Within 365 days of SIP approval
Objective 2.4 Establish Feedback mechanisms with PHEMCE partners to ensure two-way communication on addressing gaps and shortfalls Within 120 days of SIP approval


Goal 3: Provide recommendations to the Secretary based on the best available evidence combined with situational awareness and field deployment realities


Objective
 Description
 Timeline
Objective 3.1
 Outline recommendations and progress made in a comprehensive portfolio that meets declared MCM priorities, including MCMs that address at-risk population and pediatric needs, to project SNS stockpiling and replenishment Within 550 days of SIP approval
Objective 3.2 Evaluate progress of all development activities: R&D, procurement, stockpiling, deployment, distribution, and utilization; using an evaluation system based on performance management best practices--including progress made in meeting timelines, allocations, benchmarks, and milestones Within 60 days of completing Objective 3.1
Objective 3.3 Outline short-, medium-, and long-term R&D priorities for the end-to-end MCM development cycle and adjust based on strategic environment and threat assessment Within 365 days of SIP approval
Objective 3.4 Regularly assess and communicate priorities in a transparent and deliberative fashion Ongoing




<-- Back                                                                                                                                                                    Next -->







PHEMCE Strategy & Implementation Plan 2022